Advicenne
Research Advicenne (ALDVI) on Bullrun: market cap EUR 19.35M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerALDVI
- ExchangePA
- CountryFrance
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 19.35M
- Financial periodFY2024
- RevenueEUR 4.97M
- Revenue growth11.6%
- Net income-EUR 6.46M
- Free cash flow-EUR 853.00K
- Gross margin-23.6%
Valuation Snapshot
latest market cap is EUR 19.35M.
About Advicenne
Advicenne S.A., a specialty pharmaceutical company, develops, commercializes, and markets treatments for rare renal diseases in France and internationally. It offers Sibnayal for the treatment of metabolic disorders, distal renal tubular acidosis, and cystinuria. The company also distributes Likozam, a formulation of clobazam for the treatment of short-term symptomatic of severe, disabling, or condition-causing anxiety unacceptable distress;
Frequently asked questions
What is Advicenne's market cap?
Advicenne's market capitalization is EUR 19.35M.
What does Advicenne do?
Advicenne S.A., a specialty pharmaceutical company, develops, commercializes, and markets treatments for rare renal diseases in France and internationally. It offers Sibnayal for the treatment of metabolic disorders, distal renal tubular acidosis, and cystinuria.